158 related articles for article (PubMed ID: 20664715)
21. Role of protein phosphatase 2A in mGluR5-regulated MEK/ERK phosphorylation in neurons.
Mao L; Yang L; Arora A; Choe ES; Zhang G; Liu Z; Fibuch EE; Wang JQ
J Biol Chem; 2005 Apr; 280(13):12602-10. PubMed ID: 15661743
[TBL] [Abstract][Full Text] [Related]
22. Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state.
Kohr MJ; Wang H; Wheeler DG; Velayutham M; Zweier JL; Ziolo MT
Free Radic Biol Med; 2008 Jul; 45(1):73-80. PubMed ID: 18433725
[TBL] [Abstract][Full Text] [Related]
23. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation.
Schwinger RH; Münch G; Bölck B; Karczewski P; Krause EG; Erdmann E
J Mol Cell Cardiol; 1999 Mar; 31(3):479-91. PubMed ID: 10198180
[TBL] [Abstract][Full Text] [Related]
24. Relationship between biochemical and functional effects of protein phosphatase 1 inhibitors in rabbit cardiac skinned fibers.
Berrebi-Bertrand I; Brument-Larignon N; Camelin JC; Quiniou MJ; Bril A
J Mol Cell Cardiol; 1998 Oct; 30(10):1945-54. PubMed ID: 9799649
[TBL] [Abstract][Full Text] [Related]
25. Biophysical interaction between phospholamban and protein phosphatase 1 regulatory subunit GM.
Berrebi-Bertrand I; Souchet M; Camelin JC; Laville MP; Calmels T; Bril A
FEBS Lett; 1998 Nov; 439(3):224-30. PubMed ID: 9845327
[TBL] [Abstract][Full Text] [Related]
26. Regulation of thromboxane receptor (TP) phosphorylation by protein phosphatase 1 (PP1) and PP2A.
Spurney RF
J Pharmacol Exp Ther; 2001 Feb; 296(2):592-9. PubMed ID: 11160648
[TBL] [Abstract][Full Text] [Related]
27. Regulated interaction of protein phosphatase 1 and protein phosphatase 2A with phospholipase C-related but catalytically inactive protein.
Sugiyama G; Takeuchi H; Nagano K; Gao J; Ohyama Y; Mori Y; Hirata M
Biochemistry; 2012 Apr; 51(16):3394-403. PubMed ID: 22458807
[TBL] [Abstract][Full Text] [Related]
28. Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium.
Brixius K; Wollmer A; Bölck B; Mehlhorn U; Schwinger RH
Pflugers Arch; 2003 Nov; 447(2):150-7. PubMed ID: 14530977
[TBL] [Abstract][Full Text] [Related]
29. Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban.
Wang H; Kohr MJ; Traynham CJ; Wheeler DG; Janssen PM; Ziolo MT
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1566-75. PubMed ID: 18400986
[TBL] [Abstract][Full Text] [Related]
30. Reversible phosphorylation of Bcl2 following interleukin 3 or bryostatin 1 is mediated by direct interaction with protein phosphatase 2A.
Deng X; Ito T; Carr B; Mumby M; May WS
J Biol Chem; 1998 Dec; 273(51):34157-63. PubMed ID: 9852076
[TBL] [Abstract][Full Text] [Related]
31. Phosphodiesterase 4 and phosphatase 2A differentially regulate cAMP/protein kinase a signaling for cardiac myocyte contraction under stimulation of beta1 adrenergic receptor.
De Arcangelis V; Soto D; Xiang Y
Mol Pharmacol; 2008 Nov; 74(5):1453-62. PubMed ID: 18703669
[TBL] [Abstract][Full Text] [Related]
32. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport.
Mukhopadhyay S; Webster CR; Anwer MS
J Biol Chem; 1998 Nov; 273(45):30039-45. PubMed ID: 9792726
[TBL] [Abstract][Full Text] [Related]
33. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
[TBL] [Abstract][Full Text] [Related]
34. Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart.
Lüss H; Klein-Wiele O; Bokník P; Herzig S; Knapp J; Linck B; Müller FU; Scheld HH; Schmid C; Schmitz W; Neumann J
J Mol Cell Cardiol; 2000 Dec; 32(12):2349-59. PubMed ID: 11113010
[TBL] [Abstract][Full Text] [Related]
35. The relative relevance of phosphorylation of the Thr(17) residue of phospholamban is different at different levels of beta-adrenergic stimulation.
Said M; Mundiña-Weilenmann C; Vittone L; Mattiazzi A
Pflugers Arch; 2002 Sep; 444(6):801-9. PubMed ID: 12355181
[TBL] [Abstract][Full Text] [Related]
36. Mutagenicity of nitric oxide-releasing compounds in Escherichia coli: effect of superoxide generation and evidence for two mutagenic mechanisms.
Martínez A; Urios A; Felipo V; Blanco M
Mutat Res; 2001 Oct; 497(1-2):159-67. PubMed ID: 11525919
[TBL] [Abstract][Full Text] [Related]
37. Evidence for physiological functions of protein phosphatases in the heart: evaluation with okadaic acid.
Neumann J; Boknik P; Herzig S; Schmitz W; Scholz H; Gupta RC; Watanabe AM
Am J Physiol; 1993 Jul; 265(1 Pt 2):H257-66. PubMed ID: 8393625
[TBL] [Abstract][Full Text] [Related]
38. Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure.
Currie S; Smith GL
Cardiovasc Res; 1999 Jan; 41(1):135-46. PubMed ID: 10325961
[TBL] [Abstract][Full Text] [Related]
39. Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.
Nishikawa M; Toyoda H; Saito M; Morita K; Tawara I; Deguchi K; Kuno T; Shima H; Nagao M; Shirakawa S
Cell Signal; 1994 Jan; 6(1):59-71. PubMed ID: 8011429
[TBL] [Abstract][Full Text] [Related]
40. Function and regulation of serine/threonine phosphatases in the healthy and diseased heart.
Heijman J; Dewenter M; El-Armouche A; Dobrev D
J Mol Cell Cardiol; 2013 Nov; 64():90-8. PubMed ID: 24051368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
